Kato, K.; Papageorgiou, I.; Shin, Y.-J.; Kleinhenz, J.M.; Palumbo, S.; Hahn, S.; Irish, J.D.; Rounseville, S.P.; Knox, K.S.; Hecker, L.
Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis. Antioxidants 2022, 11, 492.
https://doi.org/10.3390/antiox11030492
AMA Style
Kato K, Papageorgiou I, Shin Y-J, Kleinhenz JM, Palumbo S, Hahn S, Irish JD, Rounseville SP, Knox KS, Hecker L.
Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis. Antioxidants. 2022; 11(3):492.
https://doi.org/10.3390/antiox11030492
Chicago/Turabian Style
Kato, Kosuke, Ioannis Papageorgiou, Yoon-Joo Shin, Jennifer M. Kleinhenz, Sunny Palumbo, Seongmin Hahn, Joseph D. Irish, Skye P. Rounseville, Kenneth S. Knox, and Louise Hecker.
2022. "Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis" Antioxidants 11, no. 3: 492.
https://doi.org/10.3390/antiox11030492
APA Style
Kato, K., Papageorgiou, I., Shin, Y.-J., Kleinhenz, J. M., Palumbo, S., Hahn, S., Irish, J. D., Rounseville, S. P., Knox, K. S., & Hecker, L.
(2022). Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis. Antioxidants, 11(3), 492.
https://doi.org/10.3390/antiox11030492